Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Antimuscarinics in Older People: Dry Mouth and Beyond.

Bostock C, McDonald C.

Dent Update. 2016 Mar;43(2):186-8, 191.

PMID:
27188134
2.

Pharmaceuticals and Medical Devices: Medicare Part D.

Steiner DJ; Thomson Reuters Accelus.

Issue Brief Health Policy Track Serv. 2015 Dec 28:1-31. No abstract available.

PMID:
27116795
3.

Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression.

Bali V, Johnson ML, Chen H, Fleming ML, Holmes HM, Aparasu RR.

Ann Pharmacother. 2016 Feb;50(2):96-105. doi: 10.1177/1060028015618978. Epub 2015 Nov 25.

PMID:
26610873
4.

Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study.

Robinson DG, Schooler NR, John M, Correll CU, Marcy P, Addington J, Brunette MF, Estroff SE, Mueser KT, Penn D, Robinson J, Rosenheck RA, Severe J, Goldstein A, Azrin S, Heinssen R, Kane JM.

Am J Psychiatry. 2015 Mar 1;172(3):237-48. doi: 10.1176/appi.ajp.2014.13101355. Epub 2014 Dec 4.

5.

Retaining Part D's comprehensive coverage of antidepressants: not a silver bullet.

Bao Y, Tang Y, Donohue J.

JAMA Psychiatry. 2015 Mar;72(3):201-2. doi: 10.1001/jamapsychiatry.2014.2186. No abstract available.

6.

Patterns of Depression Treatment in Medicare Beneficiaries with Depression after Traumatic Brain Injury.

Albrecht JS, Kiptanui Z, Tsang Y, Khokhar B, Smith GS, Zuckerman IH, Simoni-Wastila L.

J Neurotrauma. 2015 Aug 15;32(16):1223-9. doi: 10.1089/neu.2014.3651. Epub 2015 Mar 25.

7.

Do medical homes increase medication adherence for persons with multiple chronic conditions?

Beadles CA, Farley JF, Ellis AR, Lichstein JC, Morrissey JP, DuBard CA, Domino ME.

Med Care. 2015 Feb;53(2):168-76. doi: 10.1097/MLR.0000000000000292.

PMID:
25517069
8.

Providing medication therapy management for smoking cessation patients.

Smalls TD, Broughton AD, Hylick EV, Woodard TJ.

J Pharm Pract. 2015 Feb;28(1):21-5. doi: 10.1177/0897190014562381. Epub 2014 Dec 11.

PMID:
25500554
9.

Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes.

Stevenson DG, O'Malley AJ, Dusetzina SB, Mitchell SL, Zarowitz BJ, Chernew ME, Newhouse JP, Huskamp HA.

J Am Geriatr Soc. 2014 Sep;62(9):1666-74. doi: 10.1111/jgs.12988. Epub 2014 Aug 14.

10.

Impact of medicare part D plan features on use of generic drugs.

Tang Y, Gellad WF, Men A, Donohue JM.

Med Care. 2014 Jun;52(6):541-8. doi: 10.1097/MLR.0000000000000142.

11.

Use of and spending on supportive care medications among Medicare beneficiaries with cancer.

Zuckerman IH, Davidoff AJ, Erten MZ, Stuart B, Shaffer T, Dougherty JS, Yong C.

Support Care Cancer. 2014 Aug;22(8):2185-95.

PMID:
24659243
12.

Generic initiation and antidepressant therapy adherence under Medicare Part D.

Bao Y, Ryan AM, Shao H, Pincus HA, Donohue JM.

Am J Manag Care. 2013 Dec;19(12):989-98.

13.

Effects of Medicare Part D on guideline-concordant pharmacotherapy for bipolar I disorder among dual beneficiaries.

Burns ME, Busch AB, Madden JM, Le Cates RF, Zhang F, Adams AS, Ross-Degnan D, Soumerai SB, Huskamp HA.

Psychiatr Serv. 2014 Mar 1;65(3):323-9. doi: 10.1176/appi.ps.201300123.

14.

National trends in the use of antidepressants between 1997 and 2009 and the role of Medicare Part D implementation.

Lim D, Jung K, Shi Y.

Psychiatr Serv. 2013 Oct;64(10):1038-42. doi: 10.1176/appi.ps.201200438.

PMID:
24081402
15.

Pharmacological management of unipolar depression.

Malhi GS, Hitching R, Berk M, Boyce P, Porter R, Fritz K.

Acta Psychiatr Scand Suppl. 2013;(443):6-23. doi: 10.1111/acps.12122. Review.

PMID:
23586873
16.

Antidepressant action of atypical antipsychotics: focus on ziprasidone monotherapy, with a few twists in the tale.

Andrade C.

J Clin Psychiatry. 2013 Mar;74(3):e193-6. doi: 10.4088/JCP.13f08410. Review. No abstract available.

17.

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.

Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S; WFSBP Task Force on Treatment Guidelines for Bipolar Disorders.

World J Biol Psychiatry. 2013 Apr;14(3):154-219. doi: 10.3109/15622975.2013.770551.

PMID:
23480132
18.

Psychopharmacotherapy of somatic symptoms disorders.

Somashekar B, Jainer A, Wuntakal B.

Int Rev Psychiatry. 2013 Feb;25(1):107-15. doi: 10.3109/09540261.2012.729758. Review.

PMID:
23383672
19.

The effect of the medication coverage gap on seniors with co-occurring depression and heart failure.

Moscarelli M, Manning W.

J Ment Health Policy Econ. 2012 Sep;15(3):103-4. No abstract available.

PMID:
23012766
20.

The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.

Baik SH, Rollman BL, Reynolds CF 3rd, Lave JR, Smith KJ, Zhang Y.

J Ment Health Policy Econ. 2012 Sep;15(3):105-18.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk